Regulatory T cells in health and disease

Cytokine

Volumn 43, Issue 3, 2008, Pages 395-401

  Piccirillo, Ciriaco A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

CD4+CD25+ regulatory T cells; Foxp3; Suppression; Tolerance

Indexed keywords

INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL CONTACT; CELL FUNCTION; CELL MATURATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY; INFLAMMATION; INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

ANIMALIA; RODENTIA;

EID: 51349168951     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.07.469     Document Type: Review

References (68)

1. Sakaguchi S., Yamaguchi T., Nomura T., and Ono M. Regulatory T cells and immune tolerance. Cell 133 5 (2008) 775-787
2. + regulatory T cells. Trends Immunol 25 (2004) 374-380
3. Gershon R.K., and Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18 (1970) 723-737
4. Bach J.F. Regulatory T cells under scrutiny. Nat Rev Immunol 3 (2003) 189-198
5. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains [CD25]. Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
6. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16 (2004) 81-88
7. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
8. Levings M.K., Allan S., d'Hennezel E., and Piccirillo C.A. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol 92 (2006) 119-155
9. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
10. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212 (2006) 8-27
11. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 7 (2006) 401-410
12. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30 (2000) 1538-1543
13. + immunoregulatory cells. J Immunol 167 (2001) 1137-1140
14. Seo S.J., Fields M.L., Buckler J.L., Reed A.J., Mandik-Nayak L., Nish S.A., et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16 (2002) 535-546
15. + and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 112 (2004) 258-267
16. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188 (1998) 287-296
17. + regulatory T cells. Nat Immunol 4 (2003) 330-336
18. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
19. + T regulatory cells. Nat Immunol 4 (2003) 337-342
20. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
21. Jaeckel E., von Boehmer H., and Manns M.P. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54 (2005) 306-310
22. Ochs H.D., Ziegler S.F., and Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol Rev 203 (2005) 156-164
23. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome [IPEX] is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
24. Gambineri E., Torgerson T.R., and Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance [IPEX], a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15 (2003) 430-435
25. Smyk-Pearson S.K., Bakke A.C., Held P.K., and Wildin R.S. Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes. Clin Exp Immunol 133 (2003) 193-199
26. Chang X., Gao J.X., Jiang Q., Wen J., Seifers N., Su L., et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 202 (2005) 1141-1151
27. + Tregs. J Clin Invest 115 (2005) 3276-3284
28. + regulatory T cells. Int Immunol 16 (2004) 1643-1656
29. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 24 (2006) 209-226
30. - regulatory T cells. J Immunol 176 (2006) 4748-4756
31. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 2 (2006) 375-387
32. Bettelli E., Dastrange M., and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 102 (2005) 5138-5143
33. Malek T.R., and Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4 (2004) 665-674
34. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 3 (2007) 371-381
35. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 5 (2008) 687-697
36. +] T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31 (2001) 1637-1645
37. Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., and Farrar M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 178 1 (2007) 280-290
38. + regulatory T cell homeostasis and the maintenance of self-tolerance. J Immunol 171 (2003) 3435-3441
39. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76 (2005) 773-779
40. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., and Verbsky J.W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119 2 (2007) 482-487
41. Malek T.R., Yu A., Vincek V., Scibelli P., and Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 (2002) 167-178
42. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
43. +] regulatory T cells by interleukin [IL]-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201 (2005) 723-735
44. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
45. +] T reg homeostasis through dendritic cell-produced IL-2. Eur J Immunol 35 (2005) 557-567
46. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 3 (2007) 329-337
47. + T cells in macaques chronically infected with SIVmac251. J Immunol 174 (2005) 1913-1921
48. +] regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194 (2001) 629-644
49. Uhlig H.H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 177 9 (2006) 5852-5860
50. Maynard C.L., Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 9 (2007) 931-941
51. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 35 (2005) 2886-2895
52. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 7169 (2007) 566-569
53. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., and Noelle R.J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174 4 (2005) 1783-1786
54. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4 (2003) 1206-1212
55. Pandiyan P., Zheng L., Ishihara S., Reed J., and Lenardo M.J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 12 (2007) 1353-1362
56. Huehn J., and Hamann A. Homing to suppress: address codes for Treg migration. Trends Immunol 26 12 (2005) 632-636
57. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169 (2002) 2461-2465
58. + regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 203 (2006) 2451-2460
59. + T-cell subset. Blood 105 (2005) 2877-2886
60. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med. 202 8 (2005) 1051-1061
61. Sather B.D., Treuting P., Perdue N., Miazgowicz M., Fontenot J.D., Rudensky A.Y., et al. Altering the distribution of Foxp3[+] regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 204 6 (2007) 1335-1347
62. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204 12 (2007) 2803-2812
63. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172 10 (2004) 5986-5993
64. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 12 (2003) 1875-1886
65. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 7090 (2006) 235-238
66. Benson M.J., Pino-Lagos K., Rosemblatt M., and Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204 8 (2007) 1765-1774
67. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 5835 (2007) 256-260
68. Coombes J.L., Siddiqui K.R., Arancibia-Cárcamo C.V., Hall J., Sun C.M., Belkaid Y., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204 8 (2007) 1757-1764